Stock Research: Raia Drogasil

Independent stock analysis through peer comparison: Get the 360° View as an objective basis for stock decision-making and explore the detailed ranks.

Raia Drogasil

SAO:RADL3 BRRADLACNOR0
52
  • Value
    17
  • Growth
    91
  • Safety
    Safety
    24
  • Combined
    41
  • Sentiment
    87
  • 360° View
    360° View
    52
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

Raia Drogasil S/A is a Brazilian company focused on the retail sale of pharmaceutical and cosmetic products. It operates in the retail pharmacy industry, selling branded and generic medications, OTC medications, and personal hygiene products. The company primarily operates in Brazil, across all federal units. In the last fiscal year, the company had a market cap of $4,152 million, profits of $1,871 million, and revenue of $6,292 million, with 64758 employees.

more
Index
BOVESPA
Renewables Users
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 19-Feb-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
17 19 7 11
Growth
91 55 97 83
Safety
Safety
24 57 50 48
Sentiment
87 46 77 85
360° View
360° View
52 37 60 71
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
47 44 45 26
Opinions Change
57 35 50 64
Pro Holdings
n/a 55 73 93
Market Pulse
71 67 84 68
Sentiment
87 46 77 85
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
17 19 7 11
Growth
91 55 97 83
Safety Safety
24 57 50 48
Combined
41 32 50 39
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
46 49 25 36
Price vs. Earnings (P/E)
10 29 15 32
Price vs. Book (P/B)
12 22 11 20
Dividend Yield
44 22 15 15
Value
17 19 7 11
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
78 92 90 75
Profit Growth
44 30 71 78
Capital Growth
90 82 65 69
Stock Returns
83 23 81 19
Growth
91 55 97 83
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
20 38 40 38
Refinancing
40 62 57 53
Liquidity
36 44 43 60
Safety Safety
24 57 50 48

Similar Stocks

Discover high‑ranked alternatives to Raia Drogasil and broaden your portfolio horizons.

Vivara Participações

SAO:VIVA3
Country: Brazil
Industry: Apparel, Accessories, Luxury
Size: Medium
Full Stock Analysis

Cogna Educacao

SAO:COGN3
Country: Brazil
Industry: Education Services
Size: Medium
Full Stock Analysis

Puregold Price Club

PHS:PGOLD
Country: Philippines
Industry: Hypermarkets, Super Centers
Size: Large
Full Stock Analysis

Telefonica Brasil

SAO:VIVT3
Country: Brazil
Industry: Integrated Telecommunication
Size: X-Large
Full Stock Analysis

Frequently Asked
Questions

This is a classic, high-risk growth play: high growth and positive sentiment outweigh low Value Rank (expensive) and risky financing. This is for aggressive growth investors who are comfortable with the high price and risk, believing the growth story justifies the expense.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing: